In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens

被引：67
|
作者：
Priebe, S [1 ]
Schwarz, S [1 ]
机构：
[1] Bundesforsch Anstalt Landwirtschaft, Inst Tierzucht, D-31535 Neustadt, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 08期
关键词：
D O I：
10.1128/AAC.47.8.2703-2705.2003
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Florfenicol in vitro activities for a total of 756 bacterial isolates from respiratory tract infections of cattle and swine were comparatively investigated by the agar diffusion method and the microdilution broth method. Florfenicol showed high in vitro activity against Pasteurella multocida, Mannheimia haemolytica, Actinobacillus pleuropneumoniae, and Streptococcus suis, with all of the isolates inhibited by less than or equal to2 mug of florfenicol per ml.
引用
收藏
页码：2703 / 2705
页数：3
相关论文
共 50 条
  • [31] Proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens
    Schwarz, Stefan
    Boettner, Alexander
    Goosens, Luc
    Hafez, H. Mohamed
    Hartmann, Katrin
    Kaske, Martin
    Kehrenberg, Corinna
    Kietzmann, Manfred
    Klarmann, Dieter
    Klein, Guenter
    Krabisch, Peter
    Luhofer, Gabriele
    Richter, Angelika
    Schulz, Bianka
    Sigge, Claudia
    Waldmann, Karl-Heinz
    Wallmann, Juergen
    Werckenthin, Christiane
    VETERINARY MICROBIOLOGY, 2008, 126 (1-3) : 178 - 188
  • [32] A vapour phase assay for evaluating the antimicrobial activities of essential oils against bovine respiratory bacterial pathogens
    Amat, S.
    Baines, D.
    Alexander, T. W.
    LETTERS IN APPLIED MICROBIOLOGY, 2017, 65 (06) : 489 - 495
  • [33] In vitro activities of oral cephem and telithromycin against clinical isolates of major respiratory pathogens in Japan
    Shimizu, Atsuyuki
    Maebashi, Kazunori
    Niida, Masashi
    Mikuniya, Takeshi
    Hikida, Muneo
    Ubukata, Kimiko
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (01) : 20 - 25
  • [34] In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens
    Dubois, J
    St-Pierre, C
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (1-2) : 35 - 40
  • [35] In vitro activity of gatifloxacin against respiratory tract pathogens from the SENTRY (Western Pacific region) program
    Bell, JM
    Turnidge, JD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 19 - 19
  • [36] In vitro activity of fluoroquinolones against common respiratory pathogens
    Aydemir, S.
    Tunger, A.
    Cilli, F.
    WEST INDIAN MEDICAL JOURNAL, 2006, 55 (01): : 9 - 12
  • [37] In vitro efficacy of ceftriaxone and cefixime against respiratory pathogens
    Kaleem, F.
    Usman, J.
    Hassan, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S88 - S88
  • [38] Grepafloxacin Activity Against 3000 Canadian Respiratory Tract Pathogens
    Daryl J. Hoban
    G. G. Zhanel
    L. Palatnick
    B. Weshnoweski
    L. Vercaigne
    J. A. Karlowsky
    Drugs, 1999, 58 : 358 - 360
  • [39] In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens
    Harding, Sarah V.
    Barnes, Kay B.
    Hawser, Stephen
    Bentley, Christine E.
    Vente, Andreas
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [40] Grepafloxacin activity against 3000 Canadian respiratory tract pathogens
    Hoban, DJ
    Zhanel, GG
    Palatnick, L
    Weshnoweski, B
    Vercaigne, L
    Karlowsky, JA
    DRUGS, 1999, 58 (Suppl 2) : 358 - 360
12345